BLT 2

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: BLT 2
Generic name: LIDOCAINE HCL
Manufacturer: CENTURA PHARMACEUTICALS INC
Product type: HUMAN OTC DRUG
SPL set ID: 41dc85ec-d79b-0a32-e054-00144ff8d46c
SPL ID: 4833cde3-82a7-dd82-e063-6394a90a63a4
Version: 8
Effective date: 2026-01-12
Source export date: 2026-09-28
Source partition: 8
Source file: https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/ae3816359e336a5de4f44607730a3d12ceb61ffa012a132189ceda22541b38ee/drug-label-0008-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:55:04

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		BLT 2	openfda.brand_name
generic name		LIDOCAINE HCL	openfda.generic_name
manufacturer name		CENTURA PHARMACEUTICALS INC	openfda.manufacturer_name
ndc	package	70372-728-01	openfda.package_ndc
ndc	product	70372-728	openfda.product_ndc
ndc11	package	70372072801	derived:openfda.package_ndc
rxcui		1858984	openfda.rxcui
spl id		4833cde3-82a7-dd82-e063-6394a90a63a4	id
spl set id		41dc85ec-d79b-0a32-e054-00144ff8d46c	set_id
unii		V13007Z41A	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS • For external use only. • Avoid contact with eyes or mucus membranes. • Do not apply to open or damaged skin. • If condition worsens or symptoms persist for more than seven days, discontinue use and consult physician. • If pregnant or breast feeding,contact physician prior to use. • Keep out of reach of children. If swallowed, contact Poison Control Center. • Do not use if allergic to any ingredient in ointment. • Do not use in large quantities, particularly over raw surfaces or blistered areas.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.